524717 — Titan Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual balance sheet for Titan Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	C2021 March 31st	R2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	18.6	54.5	68.1	48.6	28.4
Net Total Accounts Receivable
Net Total Receivables	119	190	166	221	187
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	442	588	638	683	722
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	311	338	385	491	545
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	760	1,007	1,081	1,345	1,566
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	204	193	169	204	191
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	368	320	218	246	231
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	392	688	862	1,099	1,335
Total Liabilities & Shareholders' Equity	760	1,007	1,081	1,345	1,566
Total Common Shares Outstanding